PMVP Pmv Pharmaceuticals Inc

USD 1.65 -0.01 -0.60241
Icon

Pmv Pharmaceuticals Inc (PMVP) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.65

-0.01 (-0.60)%

USD 0.12B

0.89M

USD 5.67(+243.43%)

N/A

Icon

PMVP

Pmv Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 1.65
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.12B

N/A

USD 1.65

Pmv Pharmaceuticals Inc (PMVP) Stock Forecast

Show ratings and price targets of :
USD 5.67
(+243.43%)

Based on the Pmv Pharmaceuticals Inc stock forecast from 2 analysts, the average analyst target price for Pmv Pharmaceuticals Inc is USD 5.67 over the next 12 months. Pmv Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Pmv Pharmaceuticals Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Pmv Pharmaceuticals Inc’s stock price was USD 1.65. Pmv Pharmaceuticals Inc’s stock price has changed by -1.20% over the past week, -12.23% over the past month and -67.33% over the last year.

No recent analyst target price found for Pmv Pharmaceuticals Inc
No recent average analyst rating found for Pmv Pharmaceuticals Inc

Company Overview Pmv Pharmaceuticals Inc

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein contain...Read More

https://www.pmvpharma.com

8 Clarke Drive, Cranbury, NJ, United States, 08512

62

December

USD

USA

Adjusted Closing Price for Pmv Pharmaceuticals Inc (PMVP)

Loading...

Unadjusted Closing Price for Pmv Pharmaceuticals Inc (PMVP)

Loading...

Share Trading Volume for Pmv Pharmaceuticals Inc Shares

Loading...

Compare Performance of Pmv Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PMVP

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Pmv Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S -1.36 (-1.05%) USD554.45B 46.01 4.80

ETFs Containing PMVP

Symbol Name PMVP's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Pmv Pharmaceuticals Inc (PMVP) Stock

Based on ratings from 2 analysts Pmv Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 3 buy, sell and hold ratings.

Unfortunately we do not have enough data on PMVP's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for PMVP is USD 5.67 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 5.

Unfortunately we do not have enough data on PMVP's stock to indicate if its overvalued.

The last closing price of PMVP's stock was USD 1.65.

The most recent market capitalization for PMVP is USD 0.12B.

Based on targets from 2 analysts, the average taret price for PMVP is projected at USD 5.67 over the next 12 months. This means that PMVP's stock price may go up by +243.43% over the next 12 months.

We can't find any ETFs which contains Pmv Pharmaceuticals Inc's stock.

As per our most recent records Pmv Pharmaceuticals Inc has 62 Employees.

Pmv Pharmaceuticals Inc's registered address is 8 Clarke Drive, Cranbury, NJ, United States, 08512. You can get more information about it from Pmv Pharmaceuticals Inc's website at https://www.pmvpharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...